These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 29667436)

  • 21. Fecal transplantation - the new, inexpensive, safe, and rapidly effective approach in the treatment of gastrointestinal tract diseases.
    Oprita R; Bratu M; Oprita B; Diaconescu B
    J Med Life; 2016; 9(2):160-2. PubMed ID: 27453747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients.
    Bruno G; Gagliardi A; Oliva A; Trancassini M; Macone A; Cicerone C; D'Abramo A; Iebba V; Auria S; Bonfiglio G; Zingaropoli MA; D'Ettorre G; Badiali D; Vullo V; Corazziari ES; Schippa S
    New Microbiol; 2019 Oct; 42(4):221-224. PubMed ID: 31609455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
    Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
    BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of gut microbiota in Clostridium difficile infection.
    Samarkos M; Mastrogianni E; Kampouropoulou O
    Eur J Intern Med; 2018 Apr; 50():28-32. PubMed ID: 29428498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased Complexity of Serum N-glycan Structures Associates with Successful Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Monaghan TM; Pučić-Baković M; Vučković F; Lee C; Kao D;
    Gastroenterology; 2019 Dec; 157(6):1676-1678.e3. PubMed ID: 31476300
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fecal microbiota transplantation: indications and perspectives].
    Lagier JC; Raoult D
    Med Sci (Paris); 2016 Nov; 32(11):991-997. PubMed ID: 28008840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI).
    Jiang ZD; Alexander A; Ke S; Valilis EM; Hu S; Li B; DuPont HL
    Anaerobe; 2017 Dec; 48():110-114. PubMed ID: 28801119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A different kind of "allogeneic transplant": successful fecal microbiota transplant for recurrent and refractory Clostridium difficile infection in a patient with relapsed aggressive B-cell lymphoma.
    Trubiano JA; George A; Barnett J; Siwan M; Heriot A; Prince HM; Slavin MA; Teh BW
    Leuk Lymphoma; 2015 Feb; 56(2):512-4. PubMed ID: 24828871
    [No Abstract]   [Full Text] [Related]  

  • 29. [Case series of Clostridium difficile NAP1/027/BI with novels treatments].
    Pérez-Topete SE; Miranda-Aquino T; Ayala-Gaytan JJ
    Rev Med Inst Mex Seguro Soc; 2017; 55(5):654-659. PubMed ID: 29193949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review.
    Iqbal U; Anwar H; Karim MA
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):730-734. PubMed ID: 29688901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring ways to improve CDI outcomes.
    Galpérine T; Guery B;
    Med Mal Infect; 2018 Feb; 48(1):10-17. PubMed ID: 29336930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal Microbiota Transplantation in Clostridium difficile Infection: Evidence and Indications.
    Shaukat A; Reinink AR
    Am Fam Physician; 2017 Mar; 95(6):351-352. PubMed ID: 28318210
    [No Abstract]   [Full Text] [Related]  

  • 33. Fecal microbiota transplantation for recurrent clostridium difficile infection in children.
    Chen B; Avinashi V; Dobson S
    J Infect; 2017 Jun; 74 Suppl 1():S120-S127. PubMed ID: 28646951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency.
    Tariq R; Pardi DS; Tosh PK; Walker RC; Razonable RR; Khanna S
    Clin Infect Dis; 2017 Oct; 65(10):1745-1747. PubMed ID: 29020210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal Microbiota Transplantation for Clostridium difficile Infection: A One-Center Experience.
    Lynch SM; Mu J; Grady JJ; Stevens RG; Devers TJ
    Dig Dis; 2019; 37(6):467-472. PubMed ID: 31055584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
    Borgia G; Maraolo AE; Foggia M; Buonomo AR; Gentile I
    Expert Opin Biol Ther; 2015 Jul; 15(7):1001-14. PubMed ID: 26063385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiologic factors affecting Clostridium difficile recurrence.
    Chilton CH; Pickering DS; Freeman J
    Clin Microbiol Infect; 2018 May; 24(5):476-482. PubMed ID: 29208562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of fecal microbiota transplantation suitable for mainstream medicine.
    Khoruts A; Sadowsky MJ; Hamilton MJ
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):246-50. PubMed ID: 25460566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac allograft vasculopathy following fecal microbiota transplantation for recurrent C. difficile infection.
    Barfuss S; Knackstedt ED; Jensen K; Molina K; Lal A
    Transpl Infect Dis; 2018 Dec; 20(6):e12983. PubMed ID: 30155958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.